Literature DB >> 3699879

Effects of hypertension and hypercholesterolemia on vasodilatation in the rabbit.

C E Wright, J A Angus.   

Abstract

Vasodilator substances act either directly on vascular smooth muscle (e.g., adenosine) or indirectly (e.g., acetylcholine) on endothelial cells that respond by releasing an unknown powerful, short-lived relaxing factor. To determine whether chronic hypertension or hypercholesterolemia or both would alter the release of the endothelium-derived relaxing factor, experiments were performed in hypertensive rabbits (5-week cellophane wrap perinephritis; mean blood pressure, 134.7 mm Hg) and normotensive rabbits (mean blood pressure, 80 mm Hg) with a Doppler flow transducer and perivascular balloon implanted on the lower abdominal aorta. Rabbits were fed either 1% cholesterol or control diet for 4 weeks before the experiment. On the day of the experiment, resting hindlimb vascular resistance was greatest in hypertensive rabbits fed 1% cholesterol diet, followed (in descending order) by hypertensive rabbits, normotensive rabbits fed 1% cholesterol diet, and normotensive rabbits. Pharmacological autonomic reflex blockade was induced, and steady state intravenous infusion curves to acetylcholine, serotonin, and adenosine were constructed. Sensitivity (location of effective dose, 50%) to the three vasodilator agents was altered less than twofold from the values in normotensive rabbits for any treatment group. The maximum vasodilator response to acetylcholine, but not to adenosine or serotonin, infusion was reduced significantly in the treated rabbits compared with that in normal rabbits. Reactive hyperemic responses to 5 to 80 seconds of ischemia were not significantly different among the treatment groups. These results indicate that hypertension with or without hypercholesterolemia does not greatly alter the responsiveness of the hindlimb resistance vasculature to these three vasodilator agents or to ischemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3699879     DOI: 10.1161/01.hyp.8.5.361

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Lipids and endothelium-dependent vasodilation--a review.

Authors:  Lars Lind
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

2.  Endothelial control of lower limb blood flow in chronic heart failure.

Authors:  D C Lindsay; D R Holdright; D Clarke; I S Anand; P A Poole-Wilson; P Collins
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

Review 3.  Endothelial dysfunction and atherothrombotic occlusive disease.

Authors:  J E Freedman; J Loscalzo
Journal:  Drugs       Date:  1997       Impact factor: 9.546

4.  L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.

Authors:  M A Creager; S J Gallagher; X J Girerd; S M Coleman; V J Dzau; J P Cooke
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

5.  Impaired cholinergic vasodilation in the cholesterol-fed rabbit in vivo.

Authors:  C Bossaller; H Yamamoto; P R Lichtlen; P D Henry
Journal:  Basic Res Cardiol       Date:  1987 Jul-Aug       Impact factor: 17.165

6.  Vasoconstrictor and vasodilator effects in normal and atherosclerotic conscious rabbits.

Authors:  R P Hof; A Hof
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

7.  Heterogeneous Vascular Bed Responses to Pulmonary Titanium Dioxide Nanoparticle Exposure.

Authors:  Alaeddin B Abukabda; Phoebe A Stapleton; Carroll R McBride; Jinghai Yi; Timothy R Nurkiewicz
Journal:  Front Cardiovasc Med       Date:  2017-05-24

8.  Assessment of Safety and Therapeutic Efficacy of Rosa damascena L. and Quercus infectoria on Cardiovascular Performance of Normal and Hyperlipidemic Rabbits: Physiologically Based Approach.

Authors:  Siyavash Joukar; Masoumeh Askarzadeh; Beydolah Shahouzehi; Hamid Najafipour; Hossein Fathpour
Journal:  J Toxicol       Date:  2013-09-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.